MNKD Stock Analysis: Buy, Sell, or Hold?
MNKD - Mannkind Corporation
$4.15
-0.11 (-2.58%)
▼
5d:
+7.79%
30d:
+6.68%
90d:
+25.38%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Get Alerted When MNKD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: MNKD shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: MNKD shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: MNKD is currently trading at $4.15, which is considered extended relative to its 30-day fair value range of $3.84 to $4.13. From a valuation perspective, the stock is trading at a premium (Forward PE: 32.5) compared to its historical average (24.3). At these levels, the market is pricing in 10.2% annual earnings growth.
Technical Outlook: Technically, MNKD is in a strong uptrend. Immediate support is located at $3.63, while resistance sits at $4.40.
Market Sentiment: MNKD scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.97 (+92.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MNKD is in a strong uptrend. Immediate support is located at $3.63, while resistance sits at $4.40.
Market Sentiment: MNKD scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.97 (+92.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.84 -
$4.13
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
31.9%
Protect Your Profits
Holding MNKD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (38/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 92.0% below Wall St target ($7.97)
- BULLISH: Expecting earnings turnaround to 10.2% growth with 42.9% revenue growth
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.84 -
$4.13
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.63
Resistance Level
$4.40
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
32.55
Wall Street Target
$7.97
(+92.0%)
Revenue Growth (YoY)
42.9%
Earnings Growth (YoY)
-34.9%
Profit Margin
-11.1%
Valuation Premium vs History
+10.2% premium
PE vs Historical
32.6 vs 24.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+10.2%
(market-implied from PE analysis)
1-Year Target
$4.57
(+10%)
2-Year Target
$5.04
(+21%)
3-Year Target
$5.55
(+34%)
3-Yr Target (if PE normalizes)
(PE: 33→24)
PE COMPRESSION
$4.15
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 32.5, Growth: 325.0%)
$14.01
(+238%)
Base:
(SPY PE: 20.1, Growth: 325.0%)
$8.64
(+108%)
Bear:
(PE: 17.1, Growth: 325.0%)
$7.34
(+77%)
Share & Embed Analysis
Last updated: August 23, 2026 5:48 AM ET
Data refreshes hourly during market hours. Next update: 6:48 AM
Data refreshes hourly during market hours. Next update: 6:48 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MNKD showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Michael Castagna
BUY
100000 shares
2026-03-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 50 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$125 | 41 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$138 | 66 BUY |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 37 SELL |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$101 | 50 HOLD |
Advanced MNKD Option Strategies
Professional options setups generated by AI based on today's MNKD price and gamma walls.
